Clinical trials (Patients)

Dose Escalation Study - Non Cancer Chronic Pain

CYDEPS – Dose escalation pain study – Recruitment to commence in August 2021

The CYDEPS clinical trial is investigating the use of a medical cannabis product as a potential

treatment for chronic back and/or neck pain.

The study is a single arm, open label clinical study which means everyone who participates will

receive the experimental medication (there is no placebo).

The clinical study will run for approximately 5-6 weeks, and will include 8 study visits to a medical

clinic over this time, each time seeing the study doctor. The clinical study is open to eligible

participants in Sydney.


TO BE ELIGIBLE YOU MUST:

– Be aged 18-75

– Have a history of chronic neck and/or back pain for at least 3 months

– Tried treatment with over the counter (OTC) treatments such as paracetamol and ibuprofen which haven’t worked


FURTHER DETAILS ARE AVAILABLE AT:

www.clinicaltrials.gov

ClinicalTrials.gov Identifier: NCT04976738

https://clinicaltrials.gov/ct2/show/NCT04976738?term=cymra&draw=2&rank=1#contacts

 

Observational Trial - Chronic Pain

Applied Cannabis Research has launched a national Research Study for patients suffering from chronic pain who have exhausted conventional therapies

The study is currently recruiting 300+ suitable patients over the age of 18 from across Australia through the nationwide medical chain CA Clinics.

Patients may be eligible for free doctor consultations but will incur some product costs.

ENQUIRIES – Please contact

CA Clinics
T: 1300 991 477
Einfo@caclinics.com.au

Applied Cannabis Research
P: 02 8294 6406
Einfo@appliedcannabisresearch.com.au

Contact Us

Please contact us should you wish to speak to someone about our clinical trial.